arrow
E

Eugenio Morelli

Candiolo Cancer Institute
H指数:26
被引数:2,581

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma

MDM2驱动蛋白酶体抑制剂耐药性,并在多发性骨髓瘤中代表一种TP53非依赖性的治疗易损性

Cells
IF5.2
2026-05-010
OA
Isoform-Level Long Noncoding RNA Dependencies in Multiple Myeloma

多发性骨髓瘤中isoform水平的长链非编码RNA依赖性

BLOOD
IF23.1
2024-11-050
PRE
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

KDM6A对CD38/CD48的表观遗传调控介导多发性骨髓瘤NK细胞应答

2024-02-145
OAAI
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification

多发性骨髓瘤中的DIS3耗竭导致细胞周期进程和中心体扩增的广泛扰动

2023-07-138
OAAI
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenstrom Macroglobulinemia
2022-09-128
OA
JunB is a key regulator of multiple myeloma bone marrow angiogenesis (May, 10.1038/s41375-021-01271-9, 2021)
LEUKEMIA
IF13.4
2021-09-060
OAAI
JunB is a key regulator of multiple myeloma bone marrow angiogenesis
LEUKEMIA
IF13.4
2021-05-1824
OAAI
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity
2020-02-1424
OAAI
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling
LEUKEMIA
IF13.4
2019-05-2956
OAAI
Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells
2019-02-0171
OAAI
miR-22 suppresses DNA ligase III addiction in multiple myeloma
LEUKEMIA
IF13.4
2018-08-1746
OAAI